Publications by authors named "Roy Gomez"

Claim this Profile
E
Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.
Reiko Horikawa, Toshiaki Tanaka, Yukihiro Hasegawa, Tohru Yorifuji, David Ng, Roy Gomez

Endocr J· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy and safety of weekly somatrogon with daily somatropin in Asian children living with growth hormone deficiency: a plain language summary of publication.
Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar, Der-Ming Chu, Cheol Woo Ko

Ther Adv Endocrinol Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication.
Mohamad Maghnie, Michael B Ranke, Mitchell E Geffner, Elpis Vlachopapadopoulou, Lourdes Ibáñez, Roy Gomez

Ther Adv Endocrinol Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickle cell health awareness, perspectives and experiences (SHAPE) survey: perspectives on sickle cell disease (SCD) from healthcare providers in India, Malaysia, and Thailand.
Roy Gomez, Annabel Su

Orphanet J Rare Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study.
Yen-Hung Lin, Hsu-Wen Chou, Sarah Tsai, Roy Gomez

JMIR Res Protoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing DMD management in Asia: Current challenges and future directions.
Wen-Chin Weng, Sophelia H S Chan, Roy Gomez, Furene Wang, Hsu-Wen Chou

J Neuromuscul Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.
Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar, Der-Ming Chu, Cheol Woo Ko

J Pediatr Endocrinol Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemophilia care in Asia: Learning from clinical practice in some Asian countries.
Pantep Angchaisuksiri, Marilou Amurao-Abiera, Sheng-Chien Chou, Pol Chewcharat, Novie Amelia Chozie, Roy Gomez

Haemophilia· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stigma associated with genetic testing for rare diseases-causes and recommendations.
Gareth Baynam, Roy Gomez, Ritu Jain

Front Genet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis.
Antonella Giampietro, Sabrina Chiloiro, Claudio Urbani, Rosario Pivonello, Martin Ove Carlsson, Roy Gomez

Endocr Connect· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study.
Roy Gomez, Roger Lamoureux, Diane M Turner-Bowker, Jane Loftus, Mohamad Maghnie

Front Endocrinol (Lausanne)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort".
Mohamad Maghnie, Michael B Ranke, Mitchell E Geffner, Elpis Vlachopapadopoulou, Lourdes Ibáñez, Roy Gomez

J Clin Endocrinol Metab· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort.
Mohamad Maghnie, Michael B Ranke, Mitchell E Geffner, Elpis Vlachopapadopoulou, Lourdes Ibáñez, Roy Gomez

J Clin Endocrinol Metab· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.
Reiko Horikawa, Toshiaki Tanaka, Yukihiro Hasegawa, Tohru Yorifuji, David Ng, Roy Gomez

Horm Res Paediatr· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience.
Roberto Salvatori, Pietro Maffei, Susan M Webb, Thierry Brue, Jane Loftus, Roy Gomez

Pituitary· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
Gudmundur Johannsson, Philippe Touraine, Ulla Feldt-Rasmussen, Antonio Pico, Greisa Vila, Roy Gomez

J Clin Endocrinol Metab· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan.
Marek Bolanowski, Zaina Adnan, Mirjana Doknic, Mykola Guk, Václav Hána, Roy Gomez

Front Endocrinol (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review.
Roy Gomez, S Faisal Ahmed, Mohamad Maghnie, Dejun Li, Toshiaki Tanaka

Front Endocrinol (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY.
Maria Fleseriu, Dagmar Führer-Sakel, Aart J van der Lely, Laura De Marinis, Thierry Brue, Roy Gomez

Eur J Endocrinol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004-2015).
Tal Ben-Ari, Gabriel Chodick, Varda Shalev, Dalit Goldstein, Roy Gomez

Front Pediatr· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway.
Ilan Shimon, Corin Badiu, Artur Bossowski, Mirjana Doknic, Iveta Dzivite-Krisane, Roy Gomez

Growth Horm IGF Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy.
Odile Basmaison, Bruno Ranchin, Hichem Zouater, Anna Robertson, Roy Gomez

Ann Endocrinol (Paris)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.
Thierry Brue, Anders Lindberg, Aart Jan van der Lely, Ann Charlotte Akerblad, Maria Koltowska-Häggström, Roy Gomez

Endocrine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ACRODAT, a new software medical device to assess disease activity in patients with acromegaly.
Aart J van der Lely, Roy Gomez, Andreas Pleil, Xavier Badia, Thierry Brue

Pituitary· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone.
Jane Loftus, Anders Lindberg, Ferah Aydin, Roy Gomez, Mohamad Maghnie

J Pediatr Endocrinol Metab· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis